Spyre Therapeutics, Inc.

SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636282

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 3, 20269:34 PM ETSep 1 – Sep 2, 2026King-Jones HeidySee RemarksSSaleCommon Stock−28.4K$87.3456−$2.48M2.85K−90.9%SEC10b5-1
Sep 3, 20269:33 PM ETSep 1 – Sep 2, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−25.73K$88.7541−$2.28M79.76K−24.4%SEC10b5-1
Sep 3, 20269:33 PM ETSep 1, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$87.294−$1.31M552.54K−2.6%SEC10b5-1
Aug 10, 20269:31 PM ETAug 7, 2026Albers Jeffrey W.DirectorSSaleCommon Stock−5K$104.47−$522.35K0−100.0%SEC10b5-1
Aug 10, 20269:31 PM ETAug 7, 2026Albers Jeffrey W.DirectorSSaleCommon Stock−18K$104.5467−$1.88M9.36K−65.8%SEC10b5-1
Aug 5, 20269:32 PM ETAug 3, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−7.5K$95.5695−$716.77K97.99K−7.1%SEC10b5-1
Aug 5, 20269:31 PM ETAug 3, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$95.5137−$1.43M567.54K−2.6%SEC10b5-1
Jul 2, 20269:33 PM ETJul 1, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−7.5K$87.7386−$658.04K97.99K−7.1%SEC10b5-1
Jul 2, 20269:33 PM ETJul 1, 2026Sloan SheldonChief Medical OfficerSSaleCommon Stock−8.33K$87.7005−$730.9K0−100.0%SEC10b5-1
Jul 2, 20269:32 PM ETJul 1, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$87.6898−$1.32M582.54K−2.5%SEC10b5-1
Jun 26, 2026Jun 25, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−15K$87.1333−$1.31M97.99K−13.3%SEC
Jun 23, 20269:56 PM ETJun 23, 2026Harwin Peter Evan and 3 othersDirectorSSaleCommon Stock−4.68M$85.31−$399.66M0−100.0%SEC
Jun 23, 2026Jun 22, 2026HENDERSON MICHAEL THOMASDirectorSSaleCommon Stock−20K$100.00−$2M68.61K−22.6%SEC10b5-1
Jun 3, 2026Jun 3, 2026Sloan SheldonChief Medical OfficerSSaleCommon Stock−8.33K$75.00−$624.98K0−100.0%SEC10b5-1
Jun 3, 2026Jun 1, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$70.4324−$1.06M597.54K−2.4%SEC10b5-1
Jun 3, 2026Jun 1, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−7.5K$71.0583−$532.94K97.99K−7.1%SEC10b5-1
May 8, 2026May 8, 2026HENDERSON MICHAEL THOMASDirectorSSaleCommon Stock−80K$74.4006−$5.95M88.61K−47.4%SEC10b5-1
May 1, 2026May 1, 2026Sloan SheldonChief Medical OfficerSSaleCommon Stock−78.33K$71.4986−$5.6M0−100.0%SEC10b5-1
May 1, 2026May 1, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−12.5K$71.37−$892.13K97.99K−11.3%SEC10b5-1
May 1, 2026May 1, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$71.3671−$1.07M612.54K−2.4%SEC10b5-1
Apr 3, 2026Apr 1, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−7.5K$49.3435−$370.08K97.99K−7.1%SEC10b5-1
Apr 3, 2026Apr 1, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$49.3275−$739.91K627.54K−2.3%SEC10b5-1
Apr 3, 2026Apr 1, 2026Sloan SheldonChief Medical OfficerSSaleCommon Stock−7.96K$50.00−$397.9K0−100.0%SEC10b5-1
Mar 3, 2026Mar 3, 2026Burrows Scott LChief Financial OfficerSSaleCommon Stock−2.5K$40.648−$101.62K97.99K−2.5%SEC10b5-1
Mar 3, 2026Mar 2, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$42.1911−$632.87K642.54K−2.3%SEC10b5-1
Feb 4, 2026Feb 2, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$32.803−$492.05K657.54K−2.2%SEC10b5-1
Jan 6, 2026Jan 2, 2026Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$30.6756−$460.13K671.91K−2.2%SEC10b5-1
Dec 3, 2025Dec 1, 2025Turtle CameronChief Executive OfficerSSaleCommon Stock−15K$29.0237−$435.36K686.91K−2.1%SEC10b5-1
Nov 5, 2025Nov 3, 2025Turtle CameronChief Executive OfficerSSaleCommon Stock−45K$23.3284−$1.05M701.91K−6.0%SEC10b5-1
Sep 3, 2025Sep 2, 2025Burrows Scott LChief Financial OfficerSSaleCommon Stock−18.43K$16.26−$299.64K97.99K−15.8%SEC
Nov 8, 2024Nov 6, 2024Albers Jeffrey W.DirectorSSaleCommon Stock−6.7K$36.76−$246.29K27.36K−19.7%SEC10b5-1
Oct 28, 2024Oct 25, 2024Albers Jeffrey W.DirectorSSaleCommon Stock−300$36.43−$10.93K34.06K−0.9%SEC10b5-1
Sep 5, 2024Sep 3, 2024Burrows Scott LChief Financial OfficerSSaleCommon Stock−18.53K$28.17−$522.02K116.42K−13.7%SEC
Aug 25, 2022Aug 25, 2022Souza MarcioDirectorPPurchaseCommon Stock+90K$0.56+$50.4K90KNew positionSEC
Jun 10, 2022Jun 8, 2022Hanley Jr. Michael ConickChief Commercial OfficerPPurchaseCommon Stock+28.2K$0.71+$20.02K36.2K+352.5%SEC
Mar 18, 2022Mar 16, 2022Quinn Anthony G.President & CEOPPurchaseCommon Stock+80.08K$2.34+$187.38K550.54K+17.0%SEC
Mar 15, 2022Mar 11 – Mar 15, 2022Quinn Anthony G.President & CEOPPurchaseCommon Stock+144.67K$1.9407+$280.76K473.46K+44.0%SEC
Mar 15, 2022Mar 11, 2022Alspaugh JonathanChief Financial OfficerPPurchaseCommon Stock+75K$2.08+$156K165.37K+83.0%SEC
Dec 13, 2021Dec 9 – Dec 13, 2021Shanafelt ArmenDirectorPPurchaseCommon Stock+150K$3.6662+$549.94K150KNew positionSEC
Dec 13, 2021Dec 9 – Dec 10, 2021Quinn Anthony G.President & CEOPPurchaseCommon Stock+53.63K$3.7098+$198.97K328.8K+19.5%SEC
Dec 13, 2021Dec 9, 2021Alspaugh JonathanChief Financial OfficerPPurchaseCommon Stock+50K$3.72+$186K90.37K+123.8%SEC
Aug 18, 2021Aug 16 – Aug 18, 2021Alspaugh JonathanChief Financial OfficerPPurchaseCommon Stock+40.37K$6.5077+$262.73K40.37KNew positionSEC